Hughes Hubbard welcomes IP partners James W. Dabney and Stephen S. Rabinowitz - Global Banking & Finance Review
The image features James W. Dabney and Stephen S. Rabinowitz, new partners in Hughes Hubbard's patent litigation team, enhancing their intellectual property practice.
Top Stories

HUGHES HUBBARD ADDS TWO STRONG IP PARTNERS IN NY WITH SERIOUS PATENT TRIAL BACKGROUNDS

Published by Gbaf News

Posted on September 5, 2014

3 min read
Add as preferred source on Google

Hughes Hubbard Deepens Patent Litigation Team with Partners James W. Dabney and Stephen S. Rabinowitz

Hughes Hubbard Welcomes Two Top IP Partners

Hughes Hubbard announced this week that James W. Dabney and Stephen S. Rabinowitz have joined the firm’s patent and intellectual property practice as partners in the firm’s New York office.

“Jim and Stephen have an exceptional track record in patent litigation,’ said Candace K. Beinecke, Chair of Hughes Hubbard. “Their experience will be of great value to our clients. We are delighted to welcome Jim and Stephen to Hughes Hubbard.”

Dabney and Rabinowitz’s Previous Roles

Prior to joining Hughes Hubbard, Dabney and Rabinowitz were partners at Fried, Frank, Harris, Shriver & Jacobson LLP, where Dabney was also head of that firm’s Intellectual Property and Technology Practice. They were partners at Pennie & Edmonds LLP before joining Fried, Frank. Dabney represents clients in patent matters involving diverse technologies.

Dabney’s Patent Litigation Experience

Dabney has first-chaired many patent jury trials and has also argued and won three cases in the Supreme Court of the United States including KSR International Co. v. Teleflex Inc., 550 U.S. 398 (2007). Dabney is also an adjunct professor at Cornell Law School. Rabinowitz is a medical doctor and earned a D.Phil. in Immunology from the University of Oxford. He focuses his practice on the life sciences and has litigated patent cases concerning recombinant DNA technology, nucleic acid amplification, proteins, medical diagnostics, dietary supplements, and pharmaceuticals including in Hatch-Waxman actions arising from Abbreviated New Drug Applications with Paragraph IV certifications.

“Stephen and I are thrilled to join one of the most respected litigation teams in the country,” said Dabney. “Hughes Hubbard has a long and respected history, and our clients will benefit from the deep knowledge of the patent lawyers, technical advisors, and litigators throughout the firm.”

Impressive Academic Backgrounds of New Partners

Dabney earned his A.B., magna cum laude, from Harvard and his J.D., magna cum laude, Order of the Coif from Cornell Law School, where he also served on the Board of Directors of the Cornell Law Review.

In addition to receiving his J.D., cum laude, from Harvard Law School, Rabinowitz received his M.B.,Ch.B., with honors, from the University of Cape Town. He completed his medical training and internship at Groote Schuur Hospital in Cape Town and then performed research at the Sir William Dunn School of Pathology and Balliol College, University of Oxford, where he received a D.Phil. in Immunology in 1990. He was a pathology resident at the Brigham and Women’s Hospital, Harvard Medical School.

Key Takeaways

  • Hughes Hubbard has bolstered its New York patent litigation team with two elite partners.
  • James W. Dabney brings proven trial and Supreme Court litigation success, including wins like KSR v. Teleflex.
  • Stephen S. Rabinowitz enhances the firm’s life sciences IP strength, combining medical and doctoral expertise.
  • Both partners join from Fried, Frank, after earlier careers at Pennie & Edmonds.
  • Their addition reflects Hughes Hubbard’s strategic expansion of its intellectual property litigation capabilities.

References

Frequently Asked Questions

Who are the new partners joining Hughes Hubbard?
James W. Dabney and Stephen S. Rabinowitz have joined Hughes Hubbard as partners in the firm’s New York intellectual property practice.
What notable successes does James W. Dabney bring?
Dabney has first‑chaired numerous patent jury trials and argued and won key cases before the U.S. Supreme Court, including KSR International Co. v. Teleflex Inc.
What is Stephen S. Rabinowitz’s background?
Rabinowitz is an M.B.,Ch.B. medical doctor with a D.Phil. in Immunology, focusing on life‑sciences patents including diagnostics, pharmaceuticals, and Hatch‑Waxman litigation.
From which firms did they join?
Both partners previously were at Fried, Frank, Harris, Shriver & Jacobson LLP, and before that at Pennie & Edmonds LLP.
How will their joining benefit Hughes Hubbard?
Their deep patent litigation track records and technical expertise will strengthen the firm’s ability to serve complex IP clients effectively across diverse technologies.

Tags

Related Articles

More from Top Stories

Explore more articles in the Top Stories category